June 21, 2012
Details Revealed Behind Psoriasis And Wound Repair: 2 Sides Of The Same Coin
The dynamic properties of the skin that take charge when a cut or scrape needs healing are critical for maintaining the skin's integrity, but if they get out of control, they can cause problems in the form of psoriasis and other skin disorders. Researchers reporting on June 21st in the Cell Press journal Immunity have now uncovered key information on how cells are stimulated to multiply during these processes. The information might be used to develop new treatments for psoriasis and hard-to-heal skin wounds.
For their studies, the scientists analyzed skin biopsies from individuals with and without psoriasis as well as the skin of mice with wounds on their backs and mice with psoriasis-like pathology. They found that a molecule called regenerating islet-derived protein 3-alpha (REG3A) is highly expressed in skin cells during psoriasis and wound repair, but not under normal skin conditions. Blocking REG3A delayed wound healing and cleared up psoriasis-like pathology in mice. The researchers also revealed the cascade of molecules that appear to act in conjunction with REG3A. Specifically, interleukin-17 (IL-17) binds to the IL-17 receptor A on skin cells and causes REG3A to be expressed; then REG3A binds to the exostosin-like 3 protein within cells, which activates certain enzymes that coax the cells to continue multiplying.
The findings offer potential targets for therapy. "A drug that inhibits REG3A would represent a more targeted way to treat psoriasis and avoid the systemic immunosuppression found with current therapy. Also, a drug that stimulates or mimics REG3A could be used to improve wound healing," says senior author Dr. Richard Gallo, from the University of California, San Diego.
Somewhat mysteriously, REG3A is also secreted by cells within the intestines and internal organs, where it has antimicrobial properties.
On the Net: